祝小云

博士，特聘副教授，硕士生导师

中南大学新葡的京集团35222vip(中国)集团有限公司

邮箱：zhuxiaoyun@csu.edu.cn

个人简介

祝小云，博士，特聘副教授，硕士生导师。任教于中南大学新葡的京集团35222vip(中国)集团有限公司药理学系。现任中国药理学会教学与科普专业委员会青年委员、中国药理学会中药与天然药物药理委员会青年委员、湖南省药理学会理事、湖南省生理科学会青年委员、《中国药理学通报》青年编辑委员会委员。

从事肝脏疾病的新靶点确证和天然活性物质研究。于Signal Transduction and Targeted Therapy, Journal of Hepatology, Acta Pharmaceutica Sinica B，等刊物发表第一（含共同）作者论文多篇，其中IF>30的高水平论文2篇。主持国家自然科学青年项目，湖南省自然科学优秀青年项目，第九届中国科协青年人才托举工程项目，湖南省教育厅优秀青年项目。

个人主页： https://faculty.csu.edu.cn/zhuxiaoyun

代表性论文：

1. Xiaoyun Zhu; Yanqiu Zhang; Yucheng Zhao; Dejuan Xiang; Jie Zou; Ourania Andrisani; Hao Zhang; Lingyi Kong. LIX1-like protein drives hepatic stellate cell activation to promote liver fibrosis by regulation of chemokine mRNA stability. Signal Transduction and Targeted Therapy, 2021,6(319), IF=38.104

2. Xiaoyun Zhu; Shengtao Ye; Dongke Yu; Yanqiu Zhang; Jie Li; Meihui Zhang; Yingrong Leng; Ting Yang; Jianguang Luo; Xinlin Chen; Hao Zhang; Lingyi Kong. Physalin B attenuates liver fibros is via suppressing LAP2α–HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation. British Journal of Pharmacology, 2021, (178): 3428-3447, IF=9.473

3. Jie Li#; Xiaoyun Zhu#; Meihui Zhang; Yanqiu Zhang; Shengtao Ye; Yingrong Leng; Ting Yang; Lingyi Kong; Hao Zhang. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. Journal of Hepatology, 2021, 75(2): 400-413, IF=30.083

4. Jie Zou#; Xiaoyun Zhu#; Dejuan Xiang; Yanqiu Zhang; Jie Li; Zhigui Su; Lingyi Kong; Hao Zhang. LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase. Acta Pharmaceutica Sinica B, 2021, 11(6): 1578-1591, IF=14.903

5. Dejuan Xiang#; Xiaoyun Zhu#; Yanqiu Zhang; Jie Zou; Jie Li; Lingyi Kong; Hao Zhang. Tribbles homolog 2 promotes hepatic fibrosis and hepatocarcinogenesis through phosphatase 1A‐Mediated stabilization of yes‐associated protein. Liver International, 2021, (41): 1131-1147, IF=8.754